Additional file 1 of Association between urinary phthalate metabolites and renal function in late pregnant women

Additional file 1: Figure S1. Flowchart. Table S1. Varimax-rotated factor loadings of phthalate metabolites in PCA. Table S2. Retention time, ion pair, collision energy, determination coefficient, recovery rate, and detection limit of each metabolite. Table S3. Stratified regression analysis of the association of MEHP and MEHHP with eGFR (n = 851). Table S4. Association of urinary phthalate metabolites with SUA in pregnant women without hyperuricemia and abnormal blood creatinine levels (N=770). Table S5. Association of urinary phthalate metabolites with eGFR in pregnant women without hyperuricemia and abnormal blood creatinine levels (N=770). Table S6. Association of urinary phthalate metabolites with SUA in pregnant women(N=851). Table S7. Association of urinary phthalate metabolites with eGFR in the pregnant women(N=851). Table S8. Association of urinary phthalate metabolites with SUA in pregnant women (N=851). Table S9. Association of urinary phthalate metabolites with SUA in pregnant women (N=851). Table S10. Association of urinary phthalate metabolites with UA in pregnant women (N=851). Table S11. Association of urinary phthalate metabolites with eGFR in pregnant women (N=851). Table S12. Association of urinary phthalate metabolites with eGFR in pregnant women (N=851). Excluded MIBP. Table S13. Association of urinary phthalate metabolites with UA in pregnant women (N=851). Excluded MBP.